Literature DB >> 10221442

Assessment of serum myeloperoxidase in children with bronchial asthma.

E Tauber1, Y Herouy, M Goetz, R Urbanek, E Hagel, D Y Koller.   

Abstract

BACKGROUND: The role of neutrophils and myeloperoxidase (MPO) - assumed to be a marker of neutrophil activation - in bronchial asthma is still unclear, and the literature is controversial.
METHODS: To investigate the participation of neutrophils and their products in childhood asthma, we assessed neutrophil counts and serum MPO in 175 children with bronchial asthma. Ninety of them were asymptomatic, and 85 of them were symptomatic within the last 2 weeks before examination. Bacterial infection of the lower respiratory tract (LRTI) was present in 34 and viral infection in 49 patients. As controls, 45 patients with cystic fibrosis, 23 patients with bacterial LRTI, and 87 healthy children were recruited.
RESULTS: Median neutrophil counts (3135 cells/microl) and serum MPO levels (352 microg/l) were not different in children with bronchial asthma from healthy controls (2220 cells/microl and 401 microg/l, respectively), whereas in patients with cystic fibrosis and bacterial LRTI, neutrophil counts and MPO levels were increased. Asthmatic children with bacterial infection had significantly higher serum MPO and neutrophil counts then asthmatic children with viral infection or without infection. In addition, a significant correlation was found between serum MPO and neutrophil counts and C-reactive protein (CRP), and between neutrophil counts and CRP, but no relationship was detected for serum MPO and disease activity or lung function.
CONCLUSIONS: Our data indicate that serum MPO - a marker of neutrophil activation - does not contribute to the assessment of the inflammatory process in childhood asthma. In addition, measurement of serum MPO appears not to be useful in assessing the participation of the neutrophil in asthmatic children. However, assessment of MPO may be useful to distinguish between bacterial and viral infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10221442     DOI: 10.1034/j.1398-9995.1999.00797.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  10 in total

1.  Serum Myeloperoxidase as a Biomarker of Asthma Severity Among Adults: A Case Control Study.

Authors:  Shaymaa Obaid Abdullah; Ghazi Mohamad Ramadan; Hayder Abdul-Amir Makki Al-Hindy; Mazin Jaafar Mousa; Amir Al-Mumin; Safa Jihad; Suhad Hafidh; Yaqeen Kadhum
Journal:  Rep Biochem Mol Biol       Date:  2022-04

2.  Association of Tumor Necrosis Factor-α and Myeloperoxidase enzyme with Severe Asthma: A comparative study.

Authors:  Ahmed Khalid Aldhalmi; Ali Jihad Hemid Al-Athari; Hayder Abdul-Amir Makki Al-Hindy
Journal:  Rep Biochem Mol Biol       Date:  2022-07

3.  Budesonide/Fomoterol in combination with Montelukast in the treatment of Bronchial Asthma.

Authors:  Xiaoxia Dai; Tao Feng; Xuejuan Zhang; Kaishu Li
Journal:  Pak J Med Sci       Date:  2020 Nov-Dec       Impact factor: 1.088

4.  The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation.

Authors:  Matthew T Hardison; F Shawn Galin; Christopher E Calderon; Uros V Djekic; Suzanne B Parker; Keith M Wille; Patricia L Jackson; Robert A Oster; K Randall Young; J Edwin Blalock; Amit Gaggar
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

5.  Neutrophil activation in patients with ASA-induced urticaria.

Authors:  Sung-Jin Choi; Young-Min Ye; Gyu-Young Hur; Seung-Youp Shin; Jae-Ho Han; Hae-Sim Park
Journal:  J Clin Immunol       Date:  2008-05       Impact factor: 8.317

6.  Functional variants in the catalase and myeloperoxidase genes, ambient air pollution, and respiratory-related school absences: an example of epistasis in gene-environment interactions.

Authors:  Madé Wenten; W James Gauderman; Kiros Berhane; Pi-Chu Lin; John Peters; Frank D Gilliland
Journal:  Am J Epidemiol       Date:  2009-11-06       Impact factor: 4.897

7.  Roles of the host oxidative immune response and bacterial antioxidant rubrerythrin during Porphyromonas gingivalis infection.

Authors:  Piotr Mydel; Yusuke Takahashi; Hiromichi Yumoto; Maryta Sztukowska; Malgorzata Kubica; Frank C Gibson; Donald M Kurtz; Jim Travis; L Vincent Collins; Ky-Anh Nguyen; Caroline Attardo Genco; Jan Potempa
Journal:  PLoS Pathog       Date:  2006-07       Impact factor: 6.823

8.  Down-regulation of anti-inflammatory TIPE2 may aggravate adenoidal hypertrophy in children.

Authors:  Kun Gao; Yanzhong Li; Zhiyong Yue; Jie Han; Xuanchen Zhou; Xiaoting Wang
Journal:  FEBS Open Bio       Date:  2020-03-22       Impact factor: 2.693

9.  LncRNA OIP5‑AS1 aggravates house dust mite‑induced inflammatory responses in human bronchial epithelial cells via the miR‑143‑3p/HMGB1 axis.

Authors:  Xing-Jun Cai; Lin-Hui Huang; Yi-Ke Zhu; Yi-Jiang Huang
Journal:  Mol Med Rep       Date:  2020-09-25       Impact factor: 2.952

Review 10.  Circulating biomarkers of antioxidant status and oxidative stress in people with cystic fibrosis: A systematic review and meta-analysis.

Authors:  Adam J Causer; Janis K Shute; Michael H Cummings; Anthony I Shepherd; Mathieu Gruet; Joseph T Costello; Stephen Bailey; Martin Lindley; Clare Pearson; Gary Connett; Mark I Allenby; Mary P Carroll; Thomas Daniels; Zoe L Saynor
Journal:  Redox Biol       Date:  2020-01-23       Impact factor: 11.799

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.